Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer’s disease: evidences and perspectives
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer’s disease: evidences and perspectives ; volume:17 ; number:1 ; day:23 ; month:8 ; year:2020 ; pages:1-13 ; date:12.2020
Journal of neuroinflammation ; 17, Heft 1 (23.8.2020), 1-13, 12.2020
- Creator
-
Hasselbalch, Hans C.
Skov, Vibe
Kjær, Lasse
Sørensen, Torben L.
Ellervik, Christina
Wienecke, Troels
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-020-01877-3
- URN
-
urn:nbn:de:101:1-2020101116312000542660
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hasselbalch, Hans C.
- Skov, Vibe
- Kjær, Lasse
- Sørensen, Torben L.
- Ellervik, Christina
- Wienecke, Troels
- SpringerLink (Online service)
Other Objects (12)
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells
Neuroinflammation, Its Role in Alzheimer’s Disease and Therapeutic Strategies
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Increased cysteinyl-tRNA synthetase drives neuroinflammation in Alzheimer’s disease
Neuroinflammation in Alzheimer's disease wanes with age
Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
Serum DBI and biomarkers of neuroinflammation in Alzheimer’s disease and delirium
Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells
Neuroinflammation, Its Role in Alzheimer’s Disease and Therapeutic Strategies
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Increased cysteinyl-tRNA synthetase drives neuroinflammation in Alzheimer’s disease
Neuroinflammation in Alzheimer's disease wanes with age
Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
Serum DBI and biomarkers of neuroinflammation in Alzheimer’s disease and delirium
Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells
Neuroinflammation, Its Role in Alzheimer’s Disease and Therapeutic Strategies
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Increased cysteinyl-tRNA synthetase drives neuroinflammation in Alzheimer’s disease
Neuroinflammation in Alzheimer's disease wanes with age
Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
Serum DBI and biomarkers of neuroinflammation in Alzheimer’s disease and delirium